Projected Income Statement: Amphenol Corporation

Forecast Balance Sheet: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,603 3,205 2,862 3,569 4,371 11,821 9,221 6,203
Change - -11.05% -10.7% 24.7% 22.47% 170.42% -21.99% -32.73%
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/28/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 360.4 383.8 372.8 665.4 996.6 1,230 1,307 1,428
Change - 6.49% -2.87% 78.49% 49.77% 23.41% 6.24% 9.26%
Free Cash Flow (FCF) 1 1,180 1,791 2,156 2,157 4,393 5,111 5,897 6,767
Change - 51.8% 20.39% 0.06% 103.65% 16.35% 15.37% 14.76%
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/28/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 23.64% 23.77% 23.9% 25.46% 30.19% 29.78% 30.34% 30.18%
EBIT Margin (%) 20% 20.66% 20.66% 21.69% 26.2% 26.07% 26.65% 26.98%
EBT Margin (%) 18.29% 19.55% 19.55% 19.79% 24.25% 23.64% 24.75% 26.5%
Net margin (%) 14.63% 15.07% 15.36% 15.92% 18.49% 17.89% 18.95% 19.72%
FCF margin (%) 10.85% 14.19% 17.17% 14.17% 19.02% 16.32% 16.79% 17.76%
FCF / Net Income (%) 74.16% 94.14% 111.82% 88.99% 102.87% 91.23% 88.63% 90.05%

Profitability

        
ROA 11.78% 12.43% 11.74% 12.55% 14.82% 13.65% 15.07% 16.1%
ROE 27.22% 28% 24.35% 26.27% 36.82% 35.58% 32.03% 28.05%

Financial Health

        
Leverage (Debt/EBITDA) 1.4x 1.07x 0.95x 0.92x 0.63x 1.27x 0.87x 0.54x
Debt / Free cash flow 3.05x 1.79x 1.33x 1.65x 1x 2.31x 1.56x 0.92x

Capital Intensity

        
CAPEX / Current Assets (%) 3.31% 3.04% 2.97% 4.37% 4.32% 3.93% 3.72% 3.75%
CAPEX / EBITDA (%) 14.02% 12.79% 12.42% 17.17% 14.29% 13.19% 12.27% 12.41%
CAPEX / FCF (%) 30.55% 21.43% 17.29% 30.85% 22.69% 24.06% 22.16% 21.1%

Items per share

        
Cash flow per share 1 1.231 1.751 2.037 2.228 4.207 5.232 6.087 7.47
Change - 42.22% 16.36% 9.34% 88.88% 24.37% 16.32% 22.73%
Dividend per Share 1 0.3175 0.405 0.425 0.55 0.745 1.015 1.101 1.198
Change - 27.56% 4.94% 29.41% 35.45% 36.24% 8.44% 8.85%
Book Value Per Share 1 5.038 5.649 7.009 8.097 10.94 13.94 17.9 23.06
Change - 12.13% 24.09% 15.52% 35.05% 27.46% 28.42% 28.86%
EPS 1 1.27 1.53 1.555 1.92 3.34 4.353 5.191 5.901
Change - 20.47% 1.63% 23.47% 73.96% 30.33% 19.25% 13.67%
Nbr of stocks (in thousands) 1,196,056 1,190,189 1,196,620 1,205,613 1,224,056 1,229,215 1,229,215 1,229,215
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/28/26 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 31.4x 26.3x
PBR 9.81x 7.64x
EV / Sales 5.75x 5.05x
Yield 0.74% 0.8%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
136.74USD
Average target price
169.44USD
Spread / Average Target
+23.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. APH Stock
  4. Financials Amphenol Corporation
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW